It has been reported that SAM50 deficiency triggers membrane remodeling and mitochondrial dysfunction, reducing the ability to clear reactive oxygen species (ROS) and causing lipotoxicity and hepatocyte damage, which further contributes to the development of NAFLD [10]. Here, SAMM50 is linked to metabolic dysfunction-associated steatotic liver disease.